MedPath

A prospective Study of Treatment for Renal Anemia on Prognosis in Hemodialysis Patients

Not Applicable
Conditions
Patients with renal anemia receiving erythropoietin, who have maintained dialysis therapy for over 1 year
Registration Number
JPRN-UMIN000000687
Lead Sponsor
TRAP study office
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with malignancy, infection or inflammatory diseases.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath